HUE062005T2 - Eljárások izomból származó sejtek elõállítására - Google Patents

Eljárások izomból származó sejtek elõállítására

Info

Publication number
HUE062005T2
HUE062005T2 HUE18815731A HUE18815731A HUE062005T2 HU E062005 T2 HUE062005 T2 HU E062005T2 HU E18815731 A HUE18815731 A HU E18815731A HU E18815731 A HUE18815731 A HU E18815731A HU E062005 T2 HUE062005 T2 HU E062005T2
Authority
HU
Hungary
Prior art keywords
methods
derived cells
muscle derived
obtaining muscle
obtaining
Prior art date
Application number
HUE18815731A
Other languages
English (en)
Inventor
Marco Thurner
Eva Margreiter
Wolfgang Schwaiger
Faheem Muhammad Asim
Rainer Marksteiner
Original Assignee
Innovacell Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60923243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE062005(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innovacell Ag filed Critical Innovacell Ag
Publication of HUE062005T2 publication Critical patent/HUE062005T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/71—Oxidoreductases (EC 1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
HUE18815731A 2017-12-14 2018-12-14 Eljárások izomból származó sejtek elõállítására HUE062005T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17207417 2017-12-14

Publications (1)

Publication Number Publication Date
HUE062005T2 true HUE062005T2 (hu) 2023-09-28

Family

ID=60923243

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18815731A HUE062005T2 (hu) 2017-12-14 2018-12-14 Eljárások izomból származó sejtek elõállítására

Country Status (24)

Country Link
US (2) US11617768B2 (hu)
EP (2) EP4223872A3 (hu)
JP (2) JP7361398B2 (hu)
KR (1) KR20200099173A (hu)
CN (1) CN111448307A (hu)
AU (1) AU2018383015A1 (hu)
BR (1) BR112020011853A2 (hu)
CA (1) CA3085483A1 (hu)
CL (1) CL2020001480A1 (hu)
CY (1) CY1126049T1 (hu)
DK (1) DK3724319T3 (hu)
ES (1) ES2948712T3 (hu)
FI (1) FI3724319T3 (hu)
HR (1) HRP20230474T1 (hu)
HU (1) HUE062005T2 (hu)
IL (2) IL309687A (hu)
LT (1) LT3724319T (hu)
MX (1) MX2020005881A (hu)
PL (1) PL3724319T3 (hu)
PT (1) PT3724319T (hu)
RS (1) RS64241B1 (hu)
SI (1) SI3724319T1 (hu)
WO (1) WO2019115790A1 (hu)
ZA (1) ZA202002410B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021065989A1 (hu) * 2019-09-30 2021-04-08
WO2023012334A1 (en) 2021-08-06 2023-02-09 Innovacell Ag Myogenic progenitor cells for use in an optimized method for the prevention and treatment of anal incontinence

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130141A (en) 1988-05-24 1992-07-14 Law Peter K Compositions for and methods of treating muscle degeneration and weakness
US5538722A (en) 1989-06-13 1996-07-23 Stanford University Isolation, growth, differentiation and genetic engineering of human muscle cells
AU2001251599B2 (en) 2000-04-14 2006-03-02 University Of Pittsburgh Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
KR20040039382A (ko) 2001-09-20 2004-05-10 교와 핫꼬 고교 가부시끼가이샤 골격근 간질 유래 다분화능 줄기세포
CN1812800B (zh) * 2003-04-25 2013-01-16 匹兹堡大学 用于促进和增强神经修复和再生的肌肉来源的细胞(mdc)
FR2890977A1 (fr) * 2005-09-19 2007-03-23 Assist Publ Hopitaux De Paris Procede d'obtention de cellules musculaires lisses humaines et leurs applications
US20070264712A1 (en) * 2006-01-10 2007-11-15 Theradigm, Inc. Expansion and differentiation of neural stem cells under low oxygen conditions
CA2722758C (en) * 2007-05-29 2017-04-25 Thomas Payne Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
EP2206774A1 (en) 2008-12-23 2010-07-14 Genzyme Corporation Muscle-derived cells having differentiation capacities
CN106350480B (zh) * 2016-08-26 2019-11-08 中国农业科学院北京畜牧兽医研究所 一种纯化牛胎儿骨骼肌组织来源成肌细胞的方法
BR112021016264A2 (pt) 2019-03-22 2021-10-13 Innovacell Ag Métodos para obter células musculares lisas induzidas

Also Published As

Publication number Publication date
EP4223872A2 (en) 2023-08-09
PT3724319T (pt) 2023-06-07
JP2021506285A (ja) 2021-02-22
CA3085483A1 (en) 2019-06-20
CL2020001480A1 (es) 2020-10-30
JP7361398B2 (ja) 2023-10-16
EP3724319A1 (en) 2020-10-21
SI3724319T1 (sl) 2023-07-31
MX2020005881A (es) 2020-08-13
US11617768B2 (en) 2023-04-04
EP4223872A3 (en) 2023-08-23
DK3724319T3 (da) 2023-05-01
JP2023085507A (ja) 2023-06-20
RU2020120580A (ru) 2022-01-14
EP3724319B1 (en) 2023-04-05
ZA202002410B (en) 2021-09-29
LT3724319T (lt) 2023-06-12
AU2018383015A1 (en) 2020-05-28
US20210069255A1 (en) 2021-03-11
CY1126049T1 (el) 2023-11-15
FI3724319T3 (fi) 2023-05-04
WO2019115790A1 (en) 2019-06-20
CN111448307A (zh) 2020-07-24
US20230285467A1 (en) 2023-09-14
PL3724319T3 (pl) 2023-07-24
KR20200099173A (ko) 2020-08-21
ES2948712T3 (es) 2023-09-18
IL275288A (en) 2020-07-30
BR112020011853A2 (pt) 2020-11-24
IL309687A (en) 2024-02-01
RS64241B1 (sr) 2023-06-30
HRP20230474T1 (hr) 2023-07-21

Similar Documents

Publication Publication Date Title
SG10201913404YA (en) Solid electrolyte
HK1247992A1 (zh) 高效電池測試器
SG11202002045RA (en) Cell
PL3678149T3 (pl) Sposób wytwarzania elektrolitu stałego na bazie lgps
GB201712733D0 (en) Methods & cells
IL269168A (en) single cell diagnosis
GB201707783D0 (en) Cell
GB201707143D0 (en) Method for producing cells
GB201707779D0 (en) Cell
HUE049929T2 (hu) Elektrolit galvanizáláshoz
GB201720949D0 (en) Cell
GB201718697D0 (en) Cell
GB201502579D0 (en) Cell analysis using dynamic biophysical methods
IL275288A (en) Methods for obtaining cells extracted from muscle
GB201703036D0 (en) Methods
IL269849A (en) A method for obtaining differentiated cells from progenitor cells derived from muscle
DK3615520T3 (en) Methods
GB201714718D0 (en) Cell
GB201615741D0 (en) Artificial cells
IL275421A (en) Electrochemical process
HUE056901T2 (hu) Elektrolit lítium-ion akkumulátorokhoz
PT3529262T (pt) Métodos para promover resposta de células t
GB201720343D0 (en) Cell
GB201720344D0 (en) Cell
ZA201708267B (en) Efficient battery tester